These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32795515)

  • 1. Niclosamide attenuates lung vascular remodeling in experimental pulmonary arterial hypertension.
    Braga CL; Felix NS; Teixeira DE; Vieira JB; Silva-Aguiar RP; Bose RM; Antunes MA; Rocha NN; Caruso-Neves C; Cruz FF; Rocco PRM; Silva PL
    Eur J Pharmacol; 2020 Nov; 887():173438. PubMed ID: 32795515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.
    de Mendonça L; Felix NS; Blanco NG; Da Silva JS; Ferreira TP; Abreu SC; Cruz FF; Rocha N; Silva PM; Martins V; Capelozzi VL; Zapata-Sudo G; Rocco PRM; Silva PL
    Stem Cell Res Ther; 2017 Oct; 8(1):220. PubMed ID: 28974252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the FGF receptor-1 inhibitor, infigratinib, with or without sildenafil, in experimental pulmonary arterial hypertension.
    Felix NS; de Mendonça L; Braga CL; da Silva JS; Samary CDS; Vieira JB; Cruz F; Rocha NN; Zapata-Sudo G; Rocco PRM; Silva PL
    Br J Pharmacol; 2019 Dec; 176(23):4462-4473. PubMed ID: 31351013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
    Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of baicalin against pulmonary arterial hypertension vascular remodeling through regulation of TNF-α signaling pathway.
    Xue X; Zhang S; Jiang W; Wang J; Xin Q; Sun C; Li K; Qi T; Luan Y
    Pharmacol Res Perspect; 2021 Feb; 9(1):e00703. PubMed ID: 33421306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGB1 down-regulation mediates terameprocol vascular anti-proliferative effect in experimental pulmonary hypertension.
    Nogueira-Ferreira R; Ferreira-Pinto MJ; Silva AF; Vitorino R; Justino J; Costa R; Moreira-Gonçalves D; Quignard JF; Ducret T; Savineau JP; Leite-Moreira AF; Ferreira R; Henriques-Coelho T
    J Cell Physiol; 2017 Nov; 232(11):3128-3138. PubMed ID: 28036116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroartemisinin Attenuates Pulmonary Hypertension Through Inhibition of Pulmonary Vascular Remodeling in Rats.
    Tang M; Wang R; Feng P; Dong Q; Chen W; Zhao Y; Li A; Li H; Chen J; Huang W
    J Cardiovasc Pharmacol; 2020 Sep; 76(3):337-348. PubMed ID: 32569012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Targeting of Vascular Remodeling and Right Heart Failure in Pulmonary Arterial Hypertension with a HIF-2α Inhibitor.
    Dai Z; Zhu MM; Peng Y; Machireddy N; Evans CE; Machado R; Zhang X; Zhao YY
    Am J Respir Crit Care Med; 2018 Dec; 198(11):1423-1434. PubMed ID: 29924941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension.
    Bisserier M; Katz MG; Bueno-Beti C; Brojakowska A; Zhang S; Gubara S; Kohlbrenner E; Fazal S; Fargnoli A; Dorfmuller P; Humbert M; Hata A; Goukassian DA; Sassi Y; Hadri L
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grape seed proanthocyanidin inhibits monocrotaline-induced pulmonary arterial hypertension via attenuating inflammation: in vivo and in vitro studies.
    Chen F; Wang H; Zhao J; Yan J; Meng H; Zhan H; Chen L; Yuan L
    J Nutr Biochem; 2019 May; 67():72-77. PubMed ID: 30856466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safflower injection inhibits pulmonary arterial remodeling in a monocrotaline-induced pulmonary arterial hypertension rat model.
    Chen A; Ding S; Kong L; Xu J; He F; Ru C; Lin X
    Z Naturforsch C J Biosci; 2021 Jan; 76(1-2):27-34. PubMed ID: 33725750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension.
    Mulvaney EP; Reid HM; Bialesova L; Bouchard A; Salvail D; Kinsella BT
    BMC Pulm Med; 2020 Apr; 20(1):85. PubMed ID: 32252727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth Factor Midkine Aggravates Pulmonary Arterial Hypertension via Surface Nucleolin.
    Kinoshita D; Shishido T; Takahashi T; Yokoyama M; Sugai T; Watanabe K; Tamura H; Nishiyama S; Takahashi H; Arimoto T; Miyamoto T; Watanabe T; Kishida S; Kadomatsu K; Abe JI; Takeishi Y; Konta T; Kubota I; Watanabe M
    Sci Rep; 2020 Jun; 10(1):10345. PubMed ID: 32587339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine attenuates hypoxia-induced pulmonary arterial hypertension via bone morphogenetic protein and transforming growth factor-β signaling.
    Chen M; Shen H; Zhu L; Yang H; Ye P; Liu P; Gu Y; Chen S
    J Cell Physiol; 2019 Aug; 234(10):17482-17493. PubMed ID: 30786011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formononetin attenuates monocrotaline‑induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats.
    Cai C; Xiang Y; Wu Y; Zhu N; Zhao H; Xu J; Lin W; Zeng C
    Mol Med Rep; 2019 Dec; 20(6):4984-4992. PubMed ID: 31702810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
    Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ
    Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective effect of hydrogen sulfide on monocrotaline‑induced pulmonary arterial hypertension via inhibition of the endothelial mesenchymal transition.
    Zhang H; Lin Y; Ma Y; Zhang J; Wang C; Zhang H
    Int J Mol Med; 2019 Dec; 44(6):2091-2102. PubMed ID: 31573044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Siah2 ubiquitin ligase ameliorates monocrotaline-induced pulmonary arterial remodeling through inactivation of YAP.
    Wang Q; Shi W; Zhang Q; Feng W; Wang J; Zhai C; Yan X; Li M
    Life Sci; 2020 Feb; 242():117159. PubMed ID: 31837334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.